DD
David Domzalski
President and Chief Executive Officer of VYNE Therapeutics (pre-merger)
Yarrow BioscienceRoles
Therapeutic Areas
Yarrow Bioscience Pipeline
| Drug | Indication | Phase |
|---|---|---|
| YB-101 (GS-098) | Graves' Disease | Phase 1b/2b |
President and Chief Executive Officer of VYNE Therapeutics (pre-merger)
Yarrow Bioscience| Drug | Indication | Phase |
|---|---|---|
| YB-101 (GS-098) | Graves' Disease | Phase 1b/2b |